346002
Glucagon Receptor Antagonist, Control
N-(3-Cyano-6-(1,1-dimethylpropyl)-4,5,6,7-tetrahydro-1-benzothien-2-yl)-4-bromobenzamide, hGCGR Antagonist, Control
Para preguntas en general por favor contacte a nuestro Servicio de Atención al Cliente:
Merck KGaA
Frankfurter Str. 250
64293 Darmstadt
Germany
Teléfono: +49 6151 72-0
Fax: +49 6151 72 2000
01 junio 2012
cargando
This product has been discontinued.
We apologize for the inconvenience, but we do not currently have an alternative product. We currently carry only the active form of this product, Glucagon Receptor Antagonist I (Cat. No. 346001)
A cell-permeable thienyl-amide compound that serves as an inactive control for Glucagon Receptor Antagonist (Cat. No. 346001). Displays weak affinity to hGCGR and is ineffective in preventing glucagon binding (20% inhibition at 10 µM in membranes prepared from CHO-hGCGR) and glucagon-, forskolin-, and GIP-induced cAMP production (10% inhibition in CHO-hGCGR cells). Only minimally suppresses glucagon-induced glycogenolysis in human primary hepatocytes.
| Información sobre producto | |||
|---|---|---|---|
| Form | Light yellow solid | ||
| Protect from Light | Si | ||
| Packaged under inert gas | Si | ||
| Purity | ≥95% by HPLC | ||
| Fórmula químico | C21H23BrN2OS | ||
| Número CAS | 362482-00-6 | ||
| Almacenar y enviar información | |||
|---|---|---|---|
| Categoría de alamacenamiento | +2°C to +8°C | ||
| Ship |
Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
Standard Handling |
||
